This diagram was developed along with a 3D medical animation that explains the mechanism-of-action (MoA) of a latest cancer therapy treatment called Neuvax — the immunodominant nine amino acid peptide derived from the extracellular domain of the HER2 protein. This medical illustration is part of a corporate and investor presentation.
Deliverables
High-Resolution Images
Corporate & Investor Presentation Media Kit
Client
Galena Biopharma
Suite 6, Claremont House,
22-24, Claremont Rd.,
Surbiton, Surrey,
KT6 4QU, UK
